Medicinal Research Reviews

Top Research Topics at Medicinal Research Reviews?

The topics of Pharmacology, Biochemistry, Drug, Cancer research and Computational biology are the focal point of discussions in the journal. The journal explores issues in Pharmacology which can be linked to other research areas like Receptor and Mechanism of action. The Biochemistry study tackled is a key component of adjacent topics in the area of Stereochemistry.

The study on Cancer research presented in it intersects with the topics under Cancer. The studies tackled, which mainly focus on Cancer, apply to Bioinformatics as well. It features Computational biology research that overlaps with concepts in Drug discovery.

• Pharmacology (23.85%)
• Biochemistry (15.74%)
• Drug (10.00%)

What are the most cited papers published in the journal?

• Carbonic anhydrase inhibitors (1217 citations)
• Flavonoids: Promising anticancer agents (829 citations)
• Click chemistry reactions in medicinal chemistry: applications of the 1,3-dipolar cycloaddition between azides and alkynes. (771 citations)

Research areas of the most cited articles at Medicinal Research Reviews:

The published papers mainly deal with areas of study such as Pharmacology, Biochemistry, Stereochemistry, Drug and Internal medicine. The most cited papers go beyond the discussion of Pharmacology and connect it with closely related disciplines like

• In vivo that intertwine with fields like In vitro,
• Receptor which intersects with area such as Neuroscience.. The journal articles hold forums on Drug that merge themes from other disciplines such as Clinical trial and Drug discovery.

What topics the last edition of the journal is best known for?

• Enzyme
• Gene
• Internal medicine

The previous edition focused in particular on these issues:

The scientific interests tackled in Medicinal Research Reviews are Bioinformatics, Drug, Disease, Computational biology and Cancer research. While the primary focus in it is Bioinformatics, it also dissects topics surrounding Heart failure and Myocardial infarction as a whole. The presented Drug research focuses mostly on Clinical trial and, on occasion, topics in Kinase and Repurposing.

While Computational biology is the key highlight in it, it also covered some subjects on Drug discovery and Drug development, Protease and Virology. Medicinal Research Reviews explores topics in Cancer research which can be helpful for research in disciplines like Cancer, Tumor progression, Protein kinase B and Wnt signaling pathway. While work presented in it provided substantial information on Cancer, it also covered topics in Small molecule and DNA repair.

The most cited articles from the last journal are:

• Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases. (29 citations)
• COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays. (29 citations)
• Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp). (25 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Medicinal Research Reviews (based on the number of publications) are:

• Erik De Clercq (14 papers) published 1 paper at the last edition,
• Susan L. Morris-Natschke (13 papers) published 1 paper at the last edition, 2 less than at the previous edition,
• Kuo Hsiung Lee (12 papers) published 1 paper at the last edition, 2 less than at the previous edition,
• Binghe Wang (11 papers) absent at the last edition,
• Peter P. Mager (10 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Medicinal Research Reviews (based on the number of publications) are:

• Rega Institute for Medical Research (30 papers) published 1 paper at the last edition,
• National Institutes of Health (26 papers) published 1 paper at the last edition the same number as at the previous edition,
• University of Kansas (20 papers) absent at the last edition,
• Georgia State University (20 papers) absent at the last edition,
• Chinese Academy of Sciences (18 papers) published 6 papers at the last edition, 3 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 6.61% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 11.50% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.96% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 22.12% of all publications and 58.41% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.